Moreover, NAMPT was shown to be differentially regulated in pathophysiological conditions like cancer [3], inflammatory disorders [4], heart diseases [5] and metabolic disorders, such as type 2 diabetes [6], obesity [7] and non-alcoholic fatty liver (NAFLD) [8–11]. Here, NAMPT is linked to metabolic dysfunction-associated steatotic liver disease.